scholarly journals How I treat common variable immune deficiency

Blood ◽  
2010 ◽  
Vol 116 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Charlotte Cunningham-Rundles

Abstract Common variable immunodeficiency is a rare immune deficiency, characterized by low levels of serum immunoglobulin G, A, and/or M with loss of antibody production. The diagnosis is most commonly made in adults between the ages of 20 and 40 years, but both children and older adults can be found to have this immune defect. The range of clinical manifestations is broad, including acute and chronic infections, inflammatory and autoimmune disease, and an increased incidence of cancer and lymphoma. For all these reasons, the disease phenotype is both heterogeneous and complex. Contributing to the complexity is that patient cohorts are generally small, criteria used for diagnosis vary, and the doses of replacement immune globulin differ. In addition, routines for monitoring patients over the years and protocols for the use of other biologic agents for complications have not been clarified or standardized. In the past few years, data from large patient registries have revealed that both selected laboratory markers and clinical phenotyping may aid in dissecting groups of subjects into biologically relevant categories. This review presents my approach to the diagnosis and treatment of patients with common variable immunodeficiency, with suggestions for the use of laboratory biomarkers and means of monitoring patients.

Hematology ◽  
2012 ◽  
Vol 2012 (1) ◽  
pp. 301-305 ◽  
Author(s):  
Charlotte Cunningham-Rundles

Abstract Common variable immunodeficiency (CVID) is a rare immune deficiency characterized by low levels of serum IgG, IgA, and/or IgM, with a loss of Ab production. The diagnosis is most commonly made in adults between the ages of 20 and 40 years, but both children and much older adults can be found to have this immune defect. The range of clinical manifestations is broad, including acute and chronic infections, inflammatory and autoimmune diseases, and an increased incidence of cancer and lymphoma. For all of these reasons, the disease phenotype is both heterogeneous and complex. In the past few years, data from large patient registries have revealed that both selected laboratory markers and clinical phenotyping may aid in separating groups of subjects into biologically relevant categories. CVID consists of 2 phenotypes, 1 in which infections are the characteristic and another in which impressive inflammatory and/or hematologic complications also develop, including lymphadenopathy, splenomegaly, autoimmune cytopenias, enteropathy, and/or and granulomatous disease. These phenotypes appear to be stable, are related to immunologic and inflammatory markers, and are predictive of outcomes. This review outlines current understanding about this syndrome based on studies of large cohorts, highlighting the evaluation and treatment of complications and, in particular, the autoimmune and inflammatory conditions that affect these patients.


Hematology ◽  
2019 ◽  
Vol 2019 (1) ◽  
pp. 449-456 ◽  
Author(s):  
Charlotte Cunningham-Rundles

Abstract Common variable immune deficiency (CVID) is one of the most common congenital immune defects encountered in clinical practice. The condition occurs equally in males and females, and most commonly in the 20- to 40-year-old age group. The diagnosis is made by documenting reduced serum concentrations of immunoglobulin G (IgG), IgA, and usually IgM, together with loss of protective antibodies. The genetics of this syndrome are complex and are still being unraveled, but the hallmarks for most patients, as with other immune defects, include acute and chronic infections of the sinopulmonary tract. However, other noninfectious autoimmune or inflammatory conditions may also occur in CVID, and indeed these may be the first and only sign that a significant immune defect is present. These manifestations include episodes of immune thrombocytopenia, autoimmune hemolytic anemia, or neutropenia, in addition to splenomegaly, generalized or worrisome lymphadenopathy, and malignancy, especially lymphoma. These issues commonly bring the patient to the attention of hematologists for both evaluation and treatment. This article discusses 3 cases in which patients with CVID had some of these presenting issues and what hematology input was required.


2016 ◽  
Vol 88 (8) ◽  
pp. 4-9
Author(s):  
A I Parfenov ◽  
L M Krums

The paper presents a variety of clinical manifestations of malabsorption syndrome (MAS) in celiac disease, collagenous sprue, Whipple’s disease, Crohn’s disease, intestinal lymphangiectasia, amyloidosis, common variable immune deficiency, and treatment of short bowel syndrome. It shows the specific features of the pathophysiology, diagnosis, and treatment of MAS in small bowel diseases.


2009 ◽  
Vol 49 (9) ◽  
pp. 1329-1338 ◽  
Author(s):  
Marion Malphettes ◽  
Laurence Gérard ◽  
Maryvonnick Carmagnat ◽  
Gaël Mouillot ◽  
Nicolas Vince ◽  
...  

2015 ◽  
Vol 6 ◽  
Author(s):  
Berrón-Ruiz Laura ◽  
Vargas-Hernández Alexander ◽  
Segura-Méndez Nora ◽  
López-Herrera Gabriela ◽  
Mogica-Martínez Dolores ◽  
...  

F1000Research ◽  
2012 ◽  
Vol 1 ◽  
pp. 46 ◽  
Author(s):  
Alexander V Karaulov ◽  
Irina V Sidorenko ◽  
Anna S Kapustina

Common variable immunodeficiency (CVID) is a primary immunological disease characterized predominantly by hypogammaglobulinemia. The main clinical manifestations are severe recurrent infections that often lead to structural damage of affected organs. The early start of adequate intravenous immunoglobulin therapy has significantly improved the prognosis of this serious disorder. Patients with CVID are also predisposed to autoimmune and lymphoproliferative complications. This article deals with the features of this primary immunodeficiency in adults. Clinical manifestations, immunological features and treatment concepts were gathered during 21 years of observation of such patients in Moscow. The authors suggest early predictive clinical signs of CVID in adults.


Blood ◽  
2019 ◽  
Vol 134 (21) ◽  
pp. 1787-1795 ◽  
Author(s):  
Charlotte Cunningham-Rundles

In this review, the authors describe 3 patients with common variable immunodeficiency (CVID), noting the disease manifestations most relevant to the practicing hematologist, especially autoimmune cytopenias, benign lymphoproliferation, granulomatous disease, and lymphomas such as common noninfectious complications of CVID.


2021 ◽  
Author(s):  
Itana Andrade ◽  
Fabíola Suano-Souza ◽  
Fernando Fonseca ◽  
Carolina Lago ◽  
Roseli Sarni

Abstract Background: Common variable immunodeficiency (CVID) is an innate immunity error, possibly associated with recurrent or chronic infections and autoimmune / inflammatory diseases and neoplasms. It is suggested that these conditions lead to persistent immune stimulation and increased oxidative stress. A positive impact on the survival of patients with an inborn errors of immunity was observed with advanced clinical care protocols, thus raising concerns about the risk of developing other associated chronic diseases, such as atherosclerosis. Studies suggest that selenium (Se) is a protective trace element against damage caused by oxidative stress. Thus, it is postulated that adequate consumption reduces the risk of some chronic diseases. Results: The median age of CVID patients was 36.8 years, with a female predominance. Low concentrations of GPx, Se and apo A-1 were observed in the patients, besides the presence of dyslipidemia and higher concentrations of adiponectin, us-CRP, and LDLox. There was no association between the concentrations of Se and GPx and the biomarkers of lipid metabolism involved in atherosclerosis risk, except for a positive association with apo A-1 and HDL. The median of polyunsaturated fat was lower in CVID patients and the intake of zinc and retinol was higher among them when compared to controls. Conclusion: The study showed a higher risk of cardiovascular disease in CVID patients. The presence of low selenium in CVID patients points to the importance of assessing the selenium-related nutritional status in these patients.


2017 ◽  
Vol 2 (1) ◽  
pp. 26
Author(s):  
Maryam Montazeri ◽  
Mohammad Reza Ebadpour ◽  
Farideh Kouchak ◽  
Naser Esmaeili

Common variable immune deficiency disease is the most prevalent acquired immune deficiency in human being after selective immunoglobulin A deficiency. It causes reduction of immunoglobulin levels and specific antibodies production and enhancement of recurrent and chronic infections risk, especially respiratory infections. CVID patients faces increased risk of granulomatous disease, autoimmune and phenomenon and malignancy. The disease involves males and females equally. Some studies showed that early diagnosis of CVID disease and regular treatment of patients with IVIG may have an efficient role in decreasing pneumonia and frequency of hospitalization due to infections and its complications. In this study we report a 16 years old girl with CVID, without clinical history of determined infection with recurrent sinusitis.


Sign in / Sign up

Export Citation Format

Share Document